2m 2m 2m 2m 2m 2m 2m
ONKURE THERAP-A (OKUR)
NASDAQ
$4.24+$0.13 (+3.19%)
Price as of Jul 14, 2026 12:46 PM EDT- $166.0MMarket Cap
- 64.40%1-Year Change
- BiotechnologyIndustry
ONKURE THERAP-A (OKUR)
$4.24+$0.13 (+3.19%)
OKUR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.11 | ||
Change | -$0.17 (-3.97%) | ||
Open | $4.24 | ||
High | $4.24 | ||
Low | $4.00 | ||
Previous Close | $4.28 | ||
Volume | 140,723 | ||
30-Day Average Volume | 511,509 | ||
1-Week Change | -10.65% | ||
1-Month Change | -2.14% | ||
1-Year Change | 64.40% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 40.4M | ||
Total Assets | $198.7M | ||
Market Cap | $166.0M | ||
Enterprise Value | -$26.1M | ||
Period: QTR TTM FY | |||
Revenue | $458,000.00 | ||
Net Income | -$15.2M | ||
Free Cash Flow | -$12.9M | ||
EBIT | -$15.2M | ||
EBITDA | -$15.1M | ||
Net Working Capital | $183.2M | ||
EPS | -$1.11 | ||
Enterprise Value/EBITDA | 2 | ||
Enterprise Value/Revenue | -57 | ||
P/B | 1 | ||
P/E | -4 | ||
PEG | 0 | ||
Price/Free Cash Flow | -13 | ||
Price/Operating Cash Flow | -13 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue